Cite
HARVARD Citation
Gousis, C. et al. (n.d.). Systemic therapies post progression on CDK4/6 inhibitors in patients with oestrogen receptor positive metastatic breast cancer: Real world data from Guy's Cancer Centre. European journal of cancer. pp. S65-. [Online].